Consistent with the literature, we noted that inhibiting FASN activity showed significant dose-dependent cell death in ABC-DLBCLs (SUDHL2, TMD8, HLY1) but modest inhibition at higher concentrations in GC-DLBCLs (SUDHL4, SUDHL6, Toledo) (Supplementary Figure 1)5,9. The gene discussed is FASN; the disease is aneurysmal bone cyst.